dotMD.com
✓ Translated by DotMD AI Clinical Council Source: Maturitas • Meta-Analysis
Verify Primary Source: NIH PubMed PMID #42066666
Plain-English Research Story • 8th-Grade Reading Level

New Insights on Effect of testosterone replacement therapy on fracture risk in hypogonadal: What a 2,711-Participant Study Found

TRT is associated with an increased incidence of predominantly non-major fractures, while the risk of major osteoporotic fractures, including hip and vertebral fractures, was not increased.

Original Paper Title: “Effect of testosterone replacement therapy on fracture risk in hypogonadal men: A systematic review and meta-analysis of randomized controlled trials” (Maturitas, 2026-06-15)

Elena Rostova (AI Quant) Rigor Score
99 / 100
Sample Size (Participants)
N = 2,711
Evidence Classification
Meta-Analysis
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • The Bottom-Line Finding: TRT is associated with an increased incidence of predominantly non-major fractures, while the risk of major osteoporotic fractures, including hip and vertebral fractures, was not increased.
  • Who Was Studied: Meta-Analysis published in Maturitas following 2,711 real-world participants.
  • Strength of the Evidence: Earned a 99/100 Study Rigor Score based on trial design, sample size, and peer-reviewed controls.
  • Smart Next Step: Share this plain-English summary with your doctor or pharmacist before starting, stopping, or changing any treatment.
The Full Story in Plain English

What the Study Found (In Plain English)

Why This Matters to You

Testosterone replacement therapy is the treatment of choice in men with hypogonadism. When you or someone you love is weighing a treatment choice, dense medical journals can feel overwhelming. Yet the core question behind this research is one that everyday patients ask all the time: does this approach actually help you feel or function better—and is it safe?

How the Study Worked

To find out, researchers writing in Maturitas conducted a meta-analysis evaluating 2,711 real-world participants. Rather than relying on guesswork or anecdotal reports, the research team tracked measurable health outcomes and day-to-day side effects under controlled clinical conditions.

What the Study Found in Plain English

TRT is associated with an increased incidence of predominantly non-major fractures, while the risk of major osteoporotic fractures, including hip and vertebral fractures, was not increased. Instead of leaving patients in the dark, these results give you and your doctor concrete data you can weigh together.

The Catch: What to Keep in Mind

Even strong medical studies have limits. Every person's body handles medicines, supplements, and lifestyle changes differently depending on age, kidney and liver health, and other prescriptions in the medicine cabinet. What worked on average in a clinical study may still need a personalized dose or a different option for you.

Bottom Line: Your Next Step

Bring this summary to your next doctor or pharmacist visit. Ask: "Based on my health history and current medications, does this research apply to me?" You can also click the formal study link below to inspect the original peer-reviewed paper directly.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Published in Maturitas (2026-06-15) • Study Design: Meta-Analysis • Participants: N = 2,711 • Biostatistical Rigor Score: 99/100. Primary Takeaway: TRT is associated with an increased incidence of predominantly non-major fractures, while the risk of major osteoporotic fractures, including hip and vertebral fractures, was not increased.

Study Limitations & Caveats Before You Act

While this meta-analysis scored 99/100 for research quality, clinical trials follow strict rules that may not match every patient's daily life. Always check with your doctor or pharmacist for drug interactions and personal risk factors before acting on new research.

Formal Peer-Reviewed Study Reference
“Effect of testosterone replacement therapy on fracture risk in hypogonadal men: A systematic review and meta-analysis of randomized controlled trials”
Published in Maturitas (2026-06-15) • PMID/ID: 42066666
Read Formal Study

Related DotMD Clinical Hubs & Price Ledgers

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 42066666: New Insights on Effect of testosterone replacement therapy on fracture risk in hypogonadal: What a 2,711-Participant Study Found

3 of 3 Free Questions Remaining